Skip to main content
logo
Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
191.00
-2.70 (-1.39%)
At close: Feb 10, 2026

Xvivo Perfusion AB Revenue

In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M SEK, down -1.25%. Xvivo Perfusion AB had revenue of 226.14M in the quarter ending December 31, 2025, a decrease of -0.62%.

Revenue
812.17M
Revenue Growth
-1.25%
P/S Ratio
7.51
Revenue / Employee
4.10M
Employees
198
Market Cap
6.10B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025812.17M-10.25M-1.25%
Dec 31, 2024822.42M224.87M37.63%
Dec 31, 2023597.54M182.25M43.88%
Dec 31, 2022415.29M156.91M60.73%
Dec 31, 2021258.39M78.53M43.66%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Elekta AB17.57B
Nolato AB9.57B
Sectra AB3.47B
Vitrolife AB3.44B
MedCap AB1.99B
BICO Group AB1.78B
CellaVision AB748.45M
C-Rad AB457.60M
Revenue Rankings

Xvivo Perfusion AB News

More News